Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.00%
)
US TECH 100
28,577.18
(
-0.04%
)
Dow Jones
49,693.20
(
0.00%
)
Brent Oil
102.74
(
-0.92%
)
Bitcoin
79,346.00
(
0.08%
)
News Focus
News Focus
Post# of 257558
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 67271

Monday, 08/22/2011 11:21:01 AM

Monday, August 22, 2011 11:21:01 AM

Post# of 257558
Plasma-protein companies are unhappy about having to pay the ObamaCare pharmaceutical fee:

http://finance.yahoo.com/news/IRS-Proposed-Regulations-on-prnews-4238685858.html?x=0&.v=1

The fee is waived for products with an FDA Orphan Drug designation, but most plasma-protein products don’t qualify for such a designation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today